MoneyWorks4Me

UPL informs about company updates

05 Mar 2018 Evaluate

Further to the letter dated February 26, 2018, UPL has now informed that the wholly-owned subsidiary, UPL Corporation (formerly Biowin Corporation Limited) has successfully completed the pricing of its $ 300 million senior unsecured notes (Notes) at 4.5 % per annum, due 2028. The Notes have been rated BBB- by Fitch, and BBB- by S&P. An application is filed to the Singapore Stock Exchange for the listing of the Notes. The offering is scheduled to close on March 8, 2018.

The above information is a part of company’s filings submitted to BSE.

UPL Share Price

564.80 -3.20 (-0.56%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 564.80
PI Industries 2500.00
Bayer CropScience 4048.15
Sharda Cropchem 787.25
Sumitomo Chem. India 564.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: